{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:12Z","timestamp":1761100512167},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2744,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p>Abstract: <jats:italic>Purpose of the study:<\/jats:italic> The aim of the study was to evaluate which patient might benefit most from allogeneic stem cell transplantation (SCT) in the treatment of relapsed and\/or refractory lymphoma. <jats:italic>Patients and methods:<\/jats:italic> Thirty\u2010eight consecutive lymphoma patients receiving either autologous (<jats:italic>n<\/jats:italic>=24) or allogeneic (<jats:italic>n<\/jats:italic>=14) stem cell grafts at our institution from 1986 to 1998 were retrospectively analysed regarding overall survival (OS), disease\u2010free survival (DFS), transplant\u2010related mortality (TRM), and relapse incidence (RI). Uni\u2010 and multivariate analyses were performed to identify patient characteristics predictive for outcome after SCT. <jats:italic>Results:<\/jats:italic> The probabilities of OS, DFS, TRM, and relapse were 57%, 51%, 29%, and 30% following autologous and 43%, 43%, 29%, and 38% following allogeneic SCT. Disease status (sensitive versus refractory) and the time interval between diagnosis and SCT were the most powerful predictive parameters for OS and TRM, whereas elevated serum LDH levels were signifcant in determining relapse. <jats:italic>Conclusions:<\/jats:italic> In patients with elevated serum LDH levels and bone marrow involvement at the time of transplantation allogeneic was superior to autologous SCT and resulted in better outcome due to a lower relapse incidence strongly suggesting the existence of a graft\u2010versus\u2010lymphoma effect.<\/jats:p>","DOI":"10.1034\/j.1600-0609.2001.00300.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T18:50:32Z","timestamp":1047408632000},"page":"43-49","source":"Crossref","is-referenced-by-count":12,"title":["Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non\u2010Hodgkin's lymphoma: a single\u2010centre experience"],"prefix":"10.1111","volume":"66","author":[{"given":"D.","family":"Nachbaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Oberaigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Nussbaumer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.7.1749.bloodjournal7371749"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706113162401"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1621"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.9.1340"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706113162402"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1200\/JCO.1990.8.4.638","article-title":"Autologous marrow transplantation for malignant lymphoma: A report of 101 cases from Seattle","volume":"8","author":"Peterson FB","year":"1990","journal-title":"J Clin Oncol"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1182\/blood.V90.10.3844","article-title":"Results of high\u2010dose therapy and autolgous bone marrow\/stem cell transplantation during remission in poor\u2010risk intermediate\u2010 and high\u2010grade lymphoma: International Index high and high\u2010intermediate risk group","volume":"90","author":"Nademanee A","year":"1997","journal-title":"Blood"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.3.1131"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909083388"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.11.1490"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.5.1096"},{"key":"e_1_2_5_14_2","first-page":"591","article-title":"Allogeneic bone marrow transplantation for poor\u2010prognosis non\u2010Hodgkin's lymphoma","volume":"12","author":"Shepherd JD","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701556"},{"key":"e_1_2_5_16_2","first-page":"299","article-title":"Allogeneic bone marrow transplantation for Hodgkin's and non\u2010Hodgkin's lymphoma","volume":"15","author":"Mendoza E","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700904"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.596"},{"key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","article-title":"Prospective comparative trial of autologous versus allogeneic marrow transplantation in patients with non\u2010Hodgkin's lymphoma","volume":"84","author":"Ratanatharathorn V","year":"1994","journal-title":"Blood"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.10.4201"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.11.1690"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","article-title":"Evidence for a graft\u2010versus\u2010lymphoma effect associated with allogeneic bone marrow transplantation","volume":"77","author":"Jones RJ","year":"1991","journal-title":"Blood"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90367-4"},{"key":"e_1_2_5_24_2","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin's disease","volume":"26","author":"Lukes RJ","year":"1966","journal-title":"Cancer Res"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.7.1329"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700981"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_5_28_2","first-page":"4","article-title":"EBMT Statistical guidelines","volume":"9","author":"Labopin M","year":"1999","journal-title":"EBMT News"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701209"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701587"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700781"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700614"},{"key":"e_1_2_5_33_2","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1182\/blood.V80.8.2142.2142","article-title":"Progressive disease after high\u2010dose therapy and autologoustransplantation for lymphoid malignanciy: clinical cours and patient follow\u2010up","volume":"15","author":"Vose JM","year":"1992","journal-title":"Blood"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.3.756"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2817"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0609.2001.00300.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0609.2001.00300.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0609.2001.00300.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:29:57Z","timestamp":1697506197000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0609.2001.00300.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1034\/j.1600-0609.2001.00300.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0609.2001.00300.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}